Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New OXCADAT Guidance and Resources to Help Patients Cope with Trauma after Intensive Care

Strategic Developments

New OXCADAT guidance and resources to help patients cope with trauma after intensive care

Wolfson Building housing stroke centre opens

Strategic Developments

Research into strokes and vascular dementia took a major step forward on Thursday 5 March with the official opening of our Wolfson Centre for the Prevention of Stroke and Dementia (CPSD) based at the new Wolfson Building.

NDCN welcomes the MRC Brain Network Dynamics Unit

Strategic Developments

We are pleased to announce that the University of Oxford MRC Brain Network Dynamics Unit joins the Nuffield Department of Clinical Neurosciences (NDCN) as a sixth division.

NHS staff across England get free access to wellbeing apps

Strategic Developments

NHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.

New Oxford Brain Health Clinical Trials Unit Open

Strategic Developments

A new Clinical Trials Unit has opened within the Department of Psychiatry - the Oxford Brain Health Clinical Trials Unit - it is the only mental health-dedicated Clinical Trials Unit in the UK. It opened in September 2019 and has replaced the former Oxford Cognitive Health and Neuroscience Clinical Trials Unit.

Oxford is joint top recruiter to drug-resitant epilepsy study

Research Highlights Strategic Developments

The Oxford Epilepsy Research Group is at the forefront of some potentially ground-breaking work with patients who have drug-resistant epilepsy. Epilepsy affects over 50 million people worldwide and nearly one in three people with epilepsy are resistant to current drugs.

Pathways to Mental Health and Academic Outcomes

Strategic Developments

The Oxford U-Flourish student wellbeing survey is part of a longitudinal study evaluating the scope of mental health need among undergraduate students. The study aims to better understand what factors determine student mental health and academic outcomes.

Building quality, diversity and publicity for mental health research

Strategic Developments

In a move that will transform future mental health research, Prof Elaine Fox has been made the national Mental Health Impact and Engagement Coordinator for UK Research and Innovation. Read more to find out more about what this means for supporting improved mental health research across the UK.

Oxford Short Course in Experimental Medicine for Mental Health - OxCEMM

Events Strategic Developments

This new course ran for the first time in January 2019, with an engaging and thought-provoking programme of talks, tours of facilities and group discussions. Feedback from participants was uniformly excellent. Applications for the January 2020 course opened on 15th August 2019.

£9 million investment for health and social care research

Major Funding Awards Strategic Developments

The NIHR Applied Research Collaboration for Oxford and Thames Valley will launch in October 2019. It is one of 15 ARC's across England, each will work with local and national partners to address some of the nation’s most pressing challenges faced by the health and care system over the next 5 years, including dementia, obesity and mental health.

Virtual Reality Could Transform Psychological Therapy in the NHS

Research Highlights Strategic Developments

A new clinical trial is testing a virtual reality (VR) based psychological therapy for people with severe mental health difficulties. gameChange is the largest ever clinical trial of virtual reality for a mental health disorder. Automated delivery of therapy using VR has potential to transform NHS provision of psychological therapy.

Launch of Oxford BioEscalator

Strategic Developments

Baroness Nicola Blackwood of North Oxford, Parliamentary Under Secretary of State for Innovation, has officially opened the Oxford BioEscalator.

Cristal Health uses industrial scale data science to improve lives

Research Highlights Strategic Developments

New spinout enterprise from Oxford seeks to accelerate evidence based innovation for treatments and services in mental health and dementia.

3-dimensional landscape of European data availability for Alzheimer’s disease research launched 3-dimensional landscape of European data availability for Alzheimer’s disease research launched

Research Highlights Strategic Developments

The ROADMAP project launches its Data Cube. The Cube offers a dynamic overview of the ‘landscape’ of data availability in Europe for Alzheimer’s disease research.

Dementias Platform UK datathon - understanding origins of dementia using machine learning

Events Strategic Developments

Using machine learning (AI) techniques to analyse complex cohort data, a group of researchers uncovered hidden patterns in cohort data that might identify those at risk of developing dementia, or indicate promising areas for research into treatments.

Thomas Willis Day 2019

Events Research Highlights Strategic Developments

On 16 May the Nuffield Department of Clinical Neurosciences celebrated the work of the previous year, marking their successes in research, teaching and public engagement

First in Europe to acquire latest MEG Technology from MEGIN

Strategic Developments

The University of Oxford is the first in Europe to acquire the latest technology in functional brain imaging. TRIUX™ neo, a magnetoencephalograph (MEG), is a highly sensitive non-invasive system for mapping the human brain.

Load More